Delivery Order SPE2DB22D1017-SPE2DB23FF9SM

Award Date 7/11/23
Potential Completion Date 7/12/23
Potential Value $365
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $607.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for TESTOSTERONE 1% (50 MG/5 G) PK UD 5GM. The contract has a period of performance from September 14, 2023 through September 15, 2023 and will be performed in Conshohocken, Pennsylvania. As the Defense Logistics Agency is responsible for worldwide logistics support of the U.S. Department of Defense, this delivery order is likely providing pharmaceutical products in support of DOD...
The Defense Logistics Agency awarded a $364,620 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of TESTOSTERONE 1% (50 MG/5 G) PK UD 5GM. The single award delivery order, issued against an unspecified governmentwide acquisition contract vehicle, calls for the pharmaceutical supplier to deliver the specified testosterone product to a facility in Conshohocken, Pennsylvania by August 1, 2023 to support DLA missions. No subcontractors or set aside designations...
The Defense Logistics Agency awarded a $4,385 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562331394 TESTOSTERONE 1% (50 MG/5 G) PK UD 5GM. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to provide pharmaceutical products in support of the DLA's medical supply chain requirements. Performance will occur at the prime contractor's facility in Conshohocken, Pennsylvania over a one day period from September...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $887.28 to Amerisourcebergen Drug Corp for the supply of 4561437023 TESTOSTERONE 1% (50 MG/5 G) PK UD 5GM. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 7-10, 2023. As the DLA is responsible for worldwide logistics support of the U.S. military, this delivery order was likely placed to support the medical supply needs of one or...
The Defense Logistics Agency awarded a $547 firm fixed price delivery order to Amerisourcebergen Drug Corporation for TESTOSTERONE 1% (50 MG/5 G) PK UD 5GM. The contract has a period of performance from July 25, 2023 through July 26, 2023 and will be performed in Conshohocken, Pennsylvania. DLA manages the Department of Defense's global supply chain and supports military services and combatant commands worldwide. This delivery order for testosterone gel is consistent with DLA's mission to...
The Defense Logistics Agency awarded a $594 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for the supply of TESTOSTERONE 1% (25MG/2.5G) PK UD 2.5GM. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The contract period of performance spans from June 27, 2023 through June 28, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support of the United States Department of Defense, this...
The Defense Logistics Agency awarded a $297 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561920630 TESTOSTERONE 1% (25MG/2.5G) PK UD 2.5GM. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order is under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. No subcontractors or set aside designations were indicated....
The Defense Logistics Agency awarded a $221.97 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562226784 TESTOSTERONE 1% (25MG/2.5G) PK UD 2.5GM. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility from September 19-20, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order supports the DLA's stocking of prescription medications for military treatment facilities on its Federal...
The Defense Logistics Agency awarded a $49,520 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for the supply of TESTOSTERONE 1% (25MG/2.5G) PK UD 2.5GM. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The contract period of performance spans from July 13, 2023 to July 14, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support of the United States Department of Defense, this delivery...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $486.16 to Amerisourcebergen Drug Corp for the supply of 4561666027 TESTOSTERONE 1% (50 MG/5 G) PK UD 5GM. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is short, spanning from August 1 to August 2, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency supports America's armed forces by...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB23FF9SM
    Delivery Order

The Defense Logistics Agency awarded a $364 firm fixed price delivery order to Amerisourcebergen Drug Corporation for TESTOSTERONE 1% (50 MG/5 G) PK UD 5GM. The contract has a period of performance from July 11, 2023 through July 12, 2023 and will be performed in Conshohocken, Pennsylvania. As a major provider of medical supplies and pharmaceuticals to the Department of Defense, this order supports DLA's mission to provide critical healthcare products to military treatment facilities on behalf of its parent agency. No major subcontractors or set aside designations were indicated.

Generated 12/17/23, 3:47 PM